{"id":"CHEMBL1040","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O","inchiKey":"JWUBBDSIWDLEOM-DTOXIADCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIFEDIOL","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcifediol"],"crossReferences":{"DailyMed":["calcifediol"],"PubChem":["144205540","26754888","50110817"],"drugbank":["DB00146"],"chEBI":["17933"]},"childChemblIds":["CHEMBL3544909","CHEMBL4594399"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","MONDO_0100096","HP_0002024","HP_0001919","EFO_0003884","EFO_0003762","MONDO_0004979","EFO_0000612","EFO_0003918","EFO_0005754"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL106708","canonicalSmiles":"O=C(O)c1ccc(-c2ccc(F)cc2)cc1","inchiKey":"LXWNTLBMNCXRQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL106708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL107498","canonicalSmiles":"CCCCCCCCCC(=O)O","inchiKey":"GHVNFZFCNZKVNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decanoic Acid","Decanoic Acid Anion"],"crossReferences":{"PubChem":["144207082","144209407","144210684","17389668","26752972","85272325"],"Wikipedia":["Decanoic_acid"],"drugbank":["DB03600"],"chEBI":["30813"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1082462","canonicalSmiles":"CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N","inchiKey":"VQKSCYBKUIDZEI-STQMWFEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DBPR-108","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DBPR-108","Dbpr-108","Prusogliptin"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1082508","canonicalSmiles":"NC(=O)NC[C@@H]1CCCc2cc(S(=O)(=O)c3cccc(F)c3)ccc21","inchiKey":"MTTHRRVVGMPYQG-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANDIPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Landipirdine","R0-5025181","R0-5025181-000","R05025181","R05025181-000","RO5025181","RO5025181-000","SYN-120","SYN120"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1084625","canonicalSmiles":"Cc1cc2c(s1)c1cnn(Cc3ccccc3F)c(=O)c1n2C","inchiKey":"IEWYEWDDQWYJLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1084625","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57646207","57646208","851783"],"drugbank":["DB07628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108545","canonicalSmiles":"COC(=O)c1ccccc1O","inchiKey":"OSWPMRLSEDHDFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL SALICYLATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aspellin","Balmosa","Bengue's balsam","Deep heat","Dubam","Gppe lin","Gppe rub","Luma","Methyl Salicylate","Nasciodine","P.r.","Radian-b","Rhodiaflor","Sloans","Thera-gesic"],"synonyms":["Betula oil","Birch oil, sweet","FEMA NO. 2745","Fema no. 2154","Fema no. 3113","Flavor,wintergreen","Gaultheria oil","Methyl salicylate","Methyl salicylate,synthetic","NSC-8204","Sweet birch oil","Teaberry oil","Wintergreen oil"],"crossReferences":{"PubChem":["144204632","144208741","144210457","17388914","26752907"],"Wikipedia":["Methyl_salicylate"],"drugbank":["DB09543"],"chEBI":["31832"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 9 approved indications."}
{"id":"CHEMBL1146","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1","inchiKey":"OLVCFLKTBJRLHI-AXAPSJFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["COMPOUND 83405","COMPOUND-83405","Cefamandole","Cephamandole","J01DC03"],"crossReferences":{"Wikipedia":["Cefamandole"],"drugbank":["DB01326"],"chEBI":["3480"]},"childChemblIds":["CHEMBL3230485","CHEMBL1360024"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1161949","canonicalSmiles":"CCCCCCCOc1cccc(C(=O)O)c1","inchiKey":"FOFZVIUYGPBWLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-(Heptyloxy)Benzoate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(Heptyloxy)Benzoate","3-(Heptyloxy)Benzoic Acid"],"crossReferences":{"drugbank":["DB07355"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1172736","canonicalSmiles":"N=C(N)NCCCCCCC(=O)N[C@@H](O)C(=O)NCCCCNCCCN","inchiKey":"IDINUJSAMVOPCM-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1172736","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Gusperimus"],"drugbank":["DB12991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200397","canonicalSmiles":"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12.Cl","inchiKey":"LJBSAUIFGPSHCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTENAFINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL990","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lotrimin ultra","Mentax","Mentax-tc"],"synonyms":["Butenafine hcl","Butenafine hydrochloride","KP-363"],"crossReferences":{"DailyMed":["butenafine%20hydrochloride"],"PubChem":["144206471"],"chEBI":["31325"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for tinea and has 3 investigational indications."}
{"id":"CHEMBL1200932","canonicalSmiles":"C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I","inchiKey":"XQZXYNRDCRIARQ-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPAMIDOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iopamidol","Iopamidol-200","Iopamidol-250","Iopamidol-300","Iopamidol-370","Isovue","Isovue-128","Isovue-200","Isovue-250","Isovue-300","Isovue-370","Isovue-m 200","Isovue-m 300","Scanlux-300","Scanlux-370"],"synonyms":["Iopamidol","Iopamiron","SQ 13,396","SQ-13396"],"crossReferences":{"DailyMed":["iopamidol"],"PubChem":["11112807","144204219","170464646"],"Wikipedia":["Iopamidol"],"drugbank":["DB08947"],"chEBI":["31711"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for hypothalamic neoplasm and glioma and has 4 investigational indications."}
{"id":"CHEMBL1200959","canonicalSmiles":"CN1CCC(CN2c3ccccc3Sc3ccccc32)C1","inchiKey":"HTMIBDQKFHUPSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHDILAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tacaryl"],"synonyms":["Methdilazine"],"crossReferences":{"Wikipedia":["Methdilazine"],"drugbank":["DB00902"],"chEBI":["6823"]},"childChemblIds":["CHEMBL1200532"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergic disease."}
{"id":"CHEMBL1201129","canonicalSmiles":"Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1","inchiKey":"XAUDJQYHKZQPEU-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECITABINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dacogen","Decitabine"],"synonyms":["2'-deoxy-5-azacytidine","DAC","Decitabine","NSC-127716"],"crossReferences":{"DailyMed":["decitabine"],"PubChem":["144205864","170465126","47211573","56324652","57260149"],"Wikipedia":["Decitabine"],"drugbank":["DB01262"],"chEBI":["50131"]},"linkedTargets":{"rows":["ENSG00000130816","ENSG00000119772"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000756","EFO_0000681","EFO_1000131","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0007160","EFO_0000339","EFO_0000096","MONDO_0002280","MONDO_0003660","EFO_0000389","EFO_0000501","EFO_0000330","EFO_0000641","MONDO_0003659","EFO_0000198","MONDO_0013730","EFO_0005922","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_0000180","EFO_0002939","HP_0001873","EFO_0000224","EFO_0001663","MONDO_0100096","MONDO_0044917","MONDO_0019472","EFO_0002428","EFO_0000574","EFO_0001378","Orphanet_232","EFO_0002913","MONDO_0007254","EFO_1001945","EFO_1001469","HP_0001915","MONDO_0002087","EFO_1000044","MONDO_0002158","EFO_1001996","EFO_1001830","EFO_0000196","EFO_0000326","EFO_0000183","MONDO_0020743","EFO_0002617","MONDO_0000430","EFO_0000616","EFO_1001779","EFO_0006859","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0003060","EFO_0000621","EFO_0000311","EFO_1001934","EFO_0000211","EFO_0000304","EFO_0008549","EFO_0010832","EFO_0003811"],"count":69},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 6 approved and 49 investigational indications."}
{"id":"CHEMBL1201179","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O","inchiKey":"XNRVGTHNYCNCFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAPATINIB DITOSYLATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL554","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tykerb"],"synonyms":["GW-572016F","GW572016F","Lapatinib","Lapatinib ditoluenesulfonate monohydrate","Lapatinib ditosylate","Lapatinib ditosylate monohydrate","Lapatinib tosilate","Lapatinib tosilate hydrate","Tycerb"],"crossReferences":{"DailyMed":["lapatinib%20ditosylate"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0003869","EFO_0006859","EFO_0002938","EFO_1001465","MONDO_0007254","EFO_1001512","EFO_0000504","EFO_0000402","MONDO_0004986","EFO_0000305","MONDO_0008315","MONDO_0020654","MONDO_0001187","EFO_1001967","MONDO_0044787","EFO_0006861","EFO_0006352","EFO_0002892","EFO_0000574","MONDO_0024880","EFO_1000158","MONDO_0044926"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 3 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201320","canonicalSmiles":"COc1ccc2[nH]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1","inchiKey":"SUBDBMMJDZJVOS-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emozul","Nexium","Nexium control","Nexium i.v.","Ventra"],"synonyms":["A02BC05","Esomeprazole","Inexium paranova","Omeprazole s-form","Omeprazole, (s)-"],"crossReferences":{"DailyMed":["esomeprazole%20magnesium","esomeprazole%20sodium","esomeprazole%20strontium"],"Wikipedia":["Esomeprazole"],"drugbank":["DB00736"],"chEBI":["50275"]},"childChemblIds":["CHEMBL1200470","CHEMBL2146140","CHEMBL2105642","CHEMBL2146133"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0003869","EFO_0001361","HP_0001600","HP_0002239","Orphanet_586","MONDO_0043839","EFO_0003882","EFO_1001951","HP_0002018","EFO_0003948","HP_0004398","MONDO_0001056","EFO_0000337","MONDO_0004247","EFO_0000676","EFO_1000961","EFO_0005762","EFO_0000616","EFO_0000280","EFO_0000685","EFO_0003756","EFO_0000217","EFO_0001645","EFO_0003898","EFO_0003758","MONDO_0007576","EFO_0003929","EFO_0004607","EFO_0007549","EFO_1001355","EFO_0004239","EFO_0008533","EFO_0004232","EFO_0002609","EFO_0009454","MP_0001914","EFO_0001422","EFO_0010282","EFO_0000574","MONDO_0004979","EFO_0000342","MONDO_0005148","MONDO_0005178","HP_0100633","MONDO_0002647","EFO_1001095","EFO_0000668"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 10 approved and 29 investigational indications."}
{"id":"CHEMBL1201574","drugType":"Unknown","blackBoxWarning":true,"name":"ONABOTULINUMTOXINA","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Botox","Botox cosmetic","Botox/botox cosmetic"],"synonyms":["Bontoxilysin","Botulin","Botulinum neurotoxin","Botulinum toxin","Botulinum toxin type a purified neurotoxin complex","Onabotulinumtoxina","Onaclostox","RTI-150","RTI150"],"crossReferences":{"DailyMed":["onabotulinumtoxina"]},"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["MONDO_0002507","HP_0001257","EFO_0009550","EFO_0000275","EFO_0006865","HP_0012228","EFO_1001909","HP_0001760","HP_0001605","EFO_0005306","EFO_0007507","EFO_1000632","EFO_0004616","HP_0006986","EFO_0003877","EFO_0009453","EFO_0005762","EFO_0002618","MONDO_0000477","HP_0012532","EFO_1000906","HP_0009926","HP_0030016","MONDO_0100431","EFO_0000546","GO_0007568","EFO_1000391","HP_0000951","EFO_0003830","EFO_1001887","EFO_0003108","EFO_1001434","EFO_1001896","EFO_0005687","HP_0000726","EFO_0000284","EFO_1000948","MONDO_0043839","HP_0012390","EFO_0009430","MONDO_0002050","EFO_0009462","HP_0000565","MONDO_0005180","EFO_0004143","HP_0000577","HP_0000011","EFO_1001092","EFO_0009625","EFO_0003897","HP_0000486","Orphanet_93955","EFO_0004269","EFO_0002916","HP_0000473","HP_0002571","EFO_0000618","EFO_0001073","EFO_0003843","HP_0002315","HP_0001347","HP_0030839","HP_0003549","EFO_0006346","HP_0000020","EFO_0004273","HP_0000975","MONDO_0043510","EFO_0004270","MONDO_0005178","EFO_0004191","HP_0000989","MONDO_0041052","MONDO_0002009","EFO_1001919","EFO_1000657","EFO_1001145","MONDO_0002471","HP_0003419","EFO_0004208","EFO_0007159","EFO_1001250","HP_0000016","EFO_0001074","HP_0009762","EFO_1001466","EFO_0005422","MONDO_0004001","EFO_1000999","EFO_0002970","EFO_1001219","EFO_1001494","EFO_0004234","EFO_0008507","EFO_0009846","MONDO_0005277","EFO_0003911","HP_0030834","EFO_0000712","EFO_0009619","EFO_1001993","EFO_1000850","HP_0001822","EFO_0005230","EFO_0008521","HP_0001337","Orphanet_523","EFO_1001054","EFO_0003894","EFO_0003899","Orphanet_98578","MONDO_0005301","EFO_1001762","EFO_1000781","EFO_0009523","EFO_0004149","HP_0002307","HP_0002019"],"count":118},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 99 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201628","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP PROTAMINE ZINC BEEF/PORK","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protamine zinc & iletin i (beef-pork)"],"synonyms":["Insulin susp protamine zinc beef/pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1966."}
{"id":"CHEMBL1201766","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O","inchiKey":"QVNNONOFASOXQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSPROPOFOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fospropofol"],"crossReferences":{"Wikipedia":["Fospropofol"],"drugbank":["DB06716"]},"childChemblIds":["CHEMBL2021422"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 2 investigational indications."}
{"id":"CHEMBL1202","canonicalSmiles":"Cl.O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O","inchiKey":"DIOIOSKKIYDRIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CIPROFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL8","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cetraxal","Ciloxan","Cipro","Ciprofloxacin hydrochloride","Proquin","Proquin xr"],"synonyms":["BAY O 9867","BAY O 9867 MONOHYDRATE","BAY-O-9867","BAY-O-9867 MONOHYDRATE","Ciflox","Ciprobay","Ciprofloxacin (as hydrochloride)","Ciprofloxacin hcl","Ciprofloxacin hydrochloride","Ciprofloxacin hydrochloride hydrate","Ciprofloxacin hydrochloride monohydrate","Ciprofloxacini hydrochloridum","Ciproxan","Ciproxin","Flociprin"],"crossReferences":{"DailyMed":["ciprofloxacin%20hydrochloride"],"PubChem":["144204263","170464757"],"chEBI":["310388"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 5 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1214124","canonicalSmiles":"N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O","inchiKey":"PRMWGUBFXWROHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERAMPANEL","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fycompa"],"synonyms":["E-2007","E2007","ER-155055-90","Perampanel"],"crossReferences":{"DailyMed":["perampanel"],"Wikipedia":["Perampanel"],"drugbank":["DB08883"],"chEBI":["71013"]},"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["HP_0002069","MONDO_0002009","HP_0000473","EFO_0001358","HP_0001250","Orphanet_2382","MONDO_0005277","EFO_1000783","EFO_0000474","EFO_0009430","EFO_0000289","MONDO_0005180","EFO_0004149","MONDO_0007079","EFO_0007262","MONDO_0004976","EFO_0003108","EFO_0003833"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for seizure and epilepsy and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229920","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"ZWPYUXAXLRFWQC-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229920","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02947"],"chEBI":["39723"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230039","canonicalSmiles":"Cc1ccc(N)cc1C","inchiKey":"DOLQYFPDPKPQSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230039","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207256","17389284","87334329"],"drugbank":["DB03018"],"chEBI":["39901"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231535","canonicalSmiles":"O=C(O)[C@@H](Cc1ccccc1)[C@H](Cc1ccc2c(c1)OCO2)C(=O)O","inchiKey":"ASEJDWRSZYAIOT-GJZGRUSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231535","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231666","canonicalSmiles":"O=C(NNS(=O)(=O)c1ccccc1C(F)(F)F)c1cc2cc(Cl)ccc2o1","inchiKey":"ZLQBZYKAQQWOTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231666","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232699","canonicalSmiles":"O=C(O)c1ccccc1C1c2ccc(O)cc2Oc2cc(O)ccc21","inchiKey":"MURGITYSBWUQTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORESCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydrofluorescein"],"crossReferences":{"drugbank":["DB07764"],"chEBI":["42492"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234647","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@@](OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@H](O)[C@@H]2O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"TXCIAUNLDRJGJZ-BILDWYJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234647","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02485"],"chEBI":["16556"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236576","canonicalSmiles":"CCCCCCCCCCC=O","inchiKey":"KMPQYAYAQWNLME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNDECANAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207736"],"drugbank":["DB04093"],"chEBI":["46202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123850","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(-c2cccnc2)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(-c2cccnc2)cc1)C(=O)N[C@H](C(=O)NC)C(C)C)C(C)C","inchiKey":"FOBRXMROTNVGST-CXPJILFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123850","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1241","canonicalSmiles":"CN(C)CCN(Cc1ccccc1)c1ccccn1","inchiKey":"UFLGIAIHIAPJJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPELENNAMINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-118946","PBZ","PBZ-SR","Tripelennamine"],"crossReferences":{"Wikipedia":["Tripelennamine"],"drugbank":["DB00792"],"chEBI":["9741"]},"childChemblIds":["CHEMBL1200769","CHEMBL1200446"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0005271"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for pruritus and allergic disease."}
{"id":"CHEMBL1258006","canonicalSmiles":"O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1","inchiKey":"OXKRFEWMSWPKKV-GHTZIAJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRADANICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATA-101","Bradanicline","TC 5619","TC-5619"],"crossReferences":{"drugbank":["DB06090"]},"childChemblIds":["CHEMBL3137311"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","HP_0012735"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1341","canonicalSmiles":"COC(F)(F)C(Cl)Cl","inchiKey":"RFKMCNOHBTXSMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXYFLURANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hepatotoxicity"," Nephrotoxicity"],"year":2001},"tradeNames":["Metofane","Penthrane","Pentrane"],"synonyms":["Analgizer","Anecotan","DA-759","Inhalan","Methoxiflurane","Methoxy flurane","Methoxyflurane","NSC-110432","Penthrox"],"crossReferences":{"Wikipedia":["Methoxyflurane"],"drugbank":["DB01028"],"chEBI":["6843"]},"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000182256","ENSG00000022355","ENSG00000102287","ENSG00000094755","ENSG00000145888","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":17},"linkedDiseases":{"rows":["EFO_0000546","HP_0001945","EFO_0001645","EFO_0003843","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever and has 2 investigational indications. It was withdrawn in United States  in 2001 due to Hepatotoxicity and  Nephrotoxicity."}
{"id":"CHEMBL13786","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O","inchiKey":"YFGBQHOOROIVKG-FKBYEOEOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"Met-Enkephalin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Met-Enkephalin"],"crossReferences":{"PubChem":["26757062"],"Wikipedia":["Met-enkephalin"],"drugbank":["DB12668"],"chEBI":["6618"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153813","canonicalSmiles":"CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccccc1","inchiKey":"LXEDKIMJQBOMSU-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL153813","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL159660","canonicalSmiles":"CC[C@@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"QIRAYNIFEOXSPW-YLJYHZDGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHAMETHADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9605","Alphamethadol","IDS-NA-010"],"crossReferences":{"drugbank":["DB01498"]},"childChemblIds":["CHEMBL2354908"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1721359","canonicalSmiles":"O=[N+]([O-])c1ccc([As](=O)(O)O)cc1","inchiKey":"FUUFQLXAIUOWML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1721359","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206311","144212591","170465716","50125868"],"drugbank":["DB11437"],"chEBI":["62629"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL173809","canonicalSmiles":"CC(C)C(C#N)(CCCN(C)CCc1ccccc1)c1ccccc1","inchiKey":"DWAWDSVKAUWFHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMOPAMIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emopamil"],"crossReferences":{"Wikipedia":["Emopamil"],"drugbank":["DB14064"],"chEBI":["34736"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1867342","canonicalSmiles":"C=CCOC(=O)C(C)(C)OC(=O)c1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)ccc1Cl","inchiKey":"JEDYYFXHPAIBGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAFENACIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211463","50113090"],"drugbank":["DB15261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2051955","canonicalSmiles":"C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1","inchiKey":"WHXMKTBCFHIYNQ-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOSIMENDAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Simdax"],"synonyms":["(-)-OR-1259","(r)-simendan","Levosimendan","NSC-759644","OR-1259","Simendan, (r)-"],"crossReferences":{"PubChem":["144205744","170466128","170466129"],"drugbank":["DB00922"],"chEBI":["50567"]},"linkedTargets":{"rows":["ENSG00000152270","ENSG00000118194","ENSG00000172572","ENSG00000114854","ENSG00000129991"],"count":5},"linkedDiseases":{"rows":["EFO_0007372","EFO_0000694","EFO_0002970","EFO_0009551","EFO_0006834","HP_0001919","EFO_0001645","EFO_0005207","EFO_0000373","EFO_0000319","EFO_1001267","EFO_0008585","EFO_0003764","EFO_0003144","EFO_0000712","EFO_1001207","MONDO_0004976","HP_0031273","EFO_0003149"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2095224","canonicalSmiles":"COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"YKUQEKXHQFYULM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRONARIDINE TETRAPHOSPHATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL35228","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-759834","Pyronaridine phosphate","Pyronaridine tetraphosphate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104993","canonicalSmiles":"Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1","inchiKey":"YQNWZWMKLDQSAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORTIOXETINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brintellix"],"synonyms":["LU AA21004","LU-AA21004","LUAA21004","Vortioxetine"],"crossReferences":{"DailyMed":["vortioxetine%20hydrobromide"],"drugbank":["DB09068"],"chEBI":["76016"]},"childChemblIds":["CHEMBL2107387","CHEMBL3260563","CHEMBL2204360"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000108576","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","MONDO_0005090","EFO_1001892","EFO_0000289","MONDO_0002050","EFO_0004262","MONDO_0002009","HP_0001268","EFO_0001421","EFO_0003761","EFO_0001358","EFO_0005230"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105635","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@H](C)O)[C@H](C)O","inchiKey":"SLYFITHISHUGLZ-LWZDQURMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DAVALINTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-2307","AC2307","Ac2307","Davalintide"],"childChemblIds":["CHEMBL2105636"],"linkedTargets":{"rows":["ENSG00000004948","ENSG00000132329","ENSG00000064989"],"count":3},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106140","canonicalSmiles":"O=S(=O)([O-])[O-].[Ca+2]","inchiKey":"OSGAYBCDTDRGGQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM SULFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alabaster","Anhydrite","Anhydrous gypsum","Anhydrous sulfate of lime","Anhydrous sulphate of lime","Basic calcium sulfate","Calcarea sulphurica","Calcii sulfas","Calcium (as sulfate)","Calcium sulfate","Calcium sulfate (1:1) dihydrate","Calcium sulfate anhydrous","Calcium sulfate dihydrate","Calcium sulfate, anhydrous","Calcium sulphate","Calcium sulphate anhydrous","Calcium sulphate, anhydrous","Calmatrix","Ci 77231","Dead-burned gypsum","Denka sigma 1000","E-516","Gypsum","Gypsum fibrosum","INS NO.516","INS-516","Insoluble anhydrite","Karstenite","Light spar","Mineral white","Muriacite","NSC-529649","Native calcium sulfate","Native calcium sulphate","Precipitated calcium sulfate","Precipitated calcium sulphate","Raddichem 27","Satin spar","Satinite","Shi gao","Shigao","Stone paste","Sulfuric acid calcium salt (1:1)","Terra alba"],"crossReferences":{"drugbank":["DB15533"],"chEBI":["31346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107328","canonicalSmiles":"CCC(CC)COC(=O)[C@@H]1C[C@H]2C[C@@H](Oc3cccc(Cl)c3-c3nnn[nH]3)CC[C@H]2CN1","inchiKey":"HPBRMCFZIGUGTK-ZMMAXQRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASOLAMPANEL ETIBUTIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dasolampanel etibutil"],"crossReferences":{"drugbank":["DB12049"]},"childChemblIds":["CHEMBL2107327"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107378","canonicalSmiles":"C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1.C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"AZPYPAVFNGFTGB-ORRJWUSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDISAMIL SESQUIFUMARATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111110","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KC-8857 SESQUIFUMARATE","KC8857","Pulzium","Tedisamil sesquifumarate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108396","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"DEFIBROTIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bos taurus lung defibrotide","Defibrotide","Defibrotide (bovine lung)","Defibrotide (bovine)"],"crossReferences":{"DrugCentral":["5092"]},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) and is indicated for recurrent thrombophlebitis and has 6 investigational indications."}
{"id":"CHEMBL2108413","drugType":"Antibody","blackBoxWarning":false,"name":"BIVATUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bivatuzumab"],"linkedTargets":{"rows":["ENSG00000026508"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0004284","EFO_0000707"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108448","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"HETASTARCH","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hespan"],"synonyms":["Hetastarch","Hydroxyethyl starch","Hydroxyethylstarch","Starch 2-hydroxyethyl ether","Starch, 2-hydroxyethyl ether"],"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2109001","drugType":"Unknown","blackBoxWarning":false,"name":"CARBOXYMETHYLCELLULOSE SODIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blandlax","Cellufresh","Celluvisc","Gppe paste","Orabase","Refresh plus, cellufresh formula"],"synonyms":["Carboxymethylcellulose sodium","Carmellose sodium","Cmc daicel 2450","Daicel 2450","Denvercel ph 2008a","E 466","E 468","E-466","Ins no.466","Ins-466","Sodium carboxymethyl cellulose","Sodium carboxymethylcellulose","Sodium cellulose glycolate","Sodium cmc"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109363","drugType":"Antibody","blackBoxWarning":false,"name":"BRE-3 90Y","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRE-3","Bre-3 90y"],"linkedTargets":{"rows":["ENSG00000140545"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109590","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-1995057","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1995057","Gsk-1995057"],"linkedTargets":{"rows":["ENSG00000067182"],"count":1},"linkedDiseases":{"rows":["EFO_0000684"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110674","canonicalSmiles":"CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"WCDDVEOXEIYWFB-VXORFPGASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYALURONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hyaluronate","Hyaluronic acid"],"childChemblIds":["CHEMBL2105008"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2111129","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTETATE INDIUM DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL2107480"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL220346","canonicalSmiles":"Nc1ncccc1NCc1cccc(-c2cccnc2)c1","inchiKey":"NQSBHBFOOVYRNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220346","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07284"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225664","canonicalSmiles":"CSc1nnc(-c2ccc(Cl)cc2)[nH]1","inchiKey":"YXVAYMRODBYXIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL225664","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL229855","canonicalSmiles":"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Br)cc4)c3)cc12","inchiKey":"VLPMRZSKJUTRBQ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL229855","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08569"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311128","canonicalSmiles":"O=C1NC(O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"UCKYOOZPSJFJIZ-XVKVHKPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2311128","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2365807","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2cccs2)CC1","inchiKey":"YPOXDUYRRSUFFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2365807","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01470"]},"childChemblIds":["CHEMBL2358736"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL247951","canonicalSmiles":"CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O","inchiKey":"ZHKNLJLMDFQVHJ-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMAFIBRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-K-13675","K-13675, (r)-","Pemafibrate"],"crossReferences":{"drugbank":["DB15212"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0009321"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL25186","canonicalSmiles":"COc1cccc(C=O)c1OP(=O)(O)O","inchiKey":"CGEZBCISRKFHLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL25186","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27769","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"NVKAWKQGWWIWPM-ABEVXSGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STANOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neodrol"],"synonyms":["4-dihydrotestosterone","5alpha-dihydrotestosterone","Anabolex","Andractim","Androstanolone","Dihydrotestosterone","Dihydrotestosterone (dht)","NSC-10972","Stanolone"],"crossReferences":{"PubChem":["144204607","144208185","144213957","17389515","50086823"],"Wikipedia":["Dihydrotestosterone"],"drugbank":["DB02901"],"chEBI":["16330"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL290429","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1","inchiKey":"YDSDEBIZUNNPOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARFENTANIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(4-carbomethoxy fentanyl)","4-carbomethoxyfentanyl","Carfentanil","Carfentanyl","R 31833"],"crossReferences":{"Wikipedia":["Carfentanil"],"drugbank":["DB01535"],"chEBI":["61084"]},"childChemblIds":["CHEMBL2106383","CHEMBL2311157"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL290814","canonicalSmiles":"CO/C1=C\\C(C)=C\\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O","inchiKey":"XDHNQDDQEHDUTM-JQWOJBOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAFILOMYCIN A1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bafilomycin A1"],"crossReferences":{"Wikipedia":["Bafilomycin"],"drugbank":["DB06733"],"chEBI":["22689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294018","canonicalSmiles":"O=C1C=C2C(=CCOC2O)O1","inchiKey":"ZRWPUFFVAOMMNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH-351633"],"crossReferences":{"PubChem":["26749249","26753752","73831"],"Wikipedia":["Patulin"],"drugbank":["DB15586"],"chEBI":["74926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297569","canonicalSmiles":"NCCC(=O)O","inchiKey":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA-ALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Amino-Propionic Acid","Beta-Alanine"],"crossReferences":{"PubChem":["11113405"],"Wikipedia":["Beta-Alanine"],"drugbank":["DB03107"],"chEBI":["16958"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3218578","canonicalSmiles":"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1","inchiKey":"BMMXYEBLEBULND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BGT-226","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGT-226","NVP-BGT226"],"crossReferences":{"chEBI":["71967"]},"childChemblIds":["CHEMBL3545096"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["Orphanet_201","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL329522","canonicalSmiles":"O=C(c1cc(O)c(O)c(O)c1)c1ccc(O)c(O)c1O","inchiKey":"XEDWWPGWIXPVRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXIFONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1989},"tradeNames":[],"synonyms":["Exifone","NSC-680919"],"crossReferences":{"PubChem":["144208648","144213864","170466234"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1989 due to Hepatotoxicity."}
{"id":"CHEMBL3302622","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1","inchiKey":"JEFVHLMGRUJLET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3302622","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01453"]},"childChemblIds":["CHEMBL3188286"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL349803","canonicalSmiles":"NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1","inchiKey":"UJEWTUDSLQGTOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRETANIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arelix","Arlix"],"synonyms":["HOE 118","HOE-118","Piretanide","S 73 4118","S-73-4118","S-734118"],"crossReferences":{"PubChem":["11112792","144204212","170465869","56463166"],"drugbank":["DB02925"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL35228","canonicalSmiles":"COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1","inchiKey":"DJUFPMUQJKWIJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRONARIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Malaridine","Pyronaridine"],"crossReferences":{"PubChem":["174006948"],"Wikipedia":["Pyronaridine"],"drugbank":["DB12975"]},"childChemblIds":["CHEMBL2095224","CHEMBL1398478"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3544922","drugType":"Antibody","blackBoxWarning":false,"name":"OPICINUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-LINGO","BIIB-033","BIIB033","Opicinumab"],"linkedTargets":{"rows":["ENSG00000169783"],"count":1},"linkedDiseases":{"rows":["EFO_0007405","MONDO_0005301","EFO_0003929"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545252","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O","inchiKey":"XCDIRYDKECHIPE-QHEQPUDQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOCETAXEL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL92","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"crossReferences":{"DailyMed":["docetaxel"],"chEBI":["59809"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003891","EFO_0011061","EFO_0000637","EFO_0003859","EFO_0004228","EFO_0000756","EFO_0000681","EFO_1000984","EFO_1001951","EFO_0000178","MONDO_0021310","EFO_0000564","MONDO_0002974","MONDO_0008903","MONDO_0001528","EFO_0008528","MONDO_0002038","MONDO_0056819","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0006911","HP_0002039","EFO_1001968","MONDO_0004986","MONDO_0008315","EFO_0001663","MONDO_0002691","Orphanet_398934","MONDO_0018201","EFO_1000527","EFO_0004284","EFO_0000574","EFO_0001378","EFO_0001376","EFO_1000412","EFO_0005577","MONDO_0021117","MONDO_0007254","MONDO_0005271","EFO_0004252","MONDO_0020654","EFO_0003817","MONDO_0001056","MONDO_0002158","EFO_1001974","EFO_0000196","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0005088","EFO_0006859","EFO_1000601","EFO_0002916","Orphanet_44890","MONDO_0007576","EFO_0000304","MONDO_0002120","MONDO_0011962","EFO_0000702","EFO_0000199","MONDO_0002367","MONDO_0024880","EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_0004281","EFO_0000571","MONDO_0004222","EFO_0000228","MONDO_0003212","EFO_0000565","MONDO_0002358","EFO_0000182","MONDO_0003199","HP_0012378","EFO_0001416","EFO_1000595","Orphanet_145","EFO_0003893","EFO_0000466","MONDO_0008170","EFO_0005842","MONDO_0004669","EFO_0007355","EFO_0009708","MONDO_0044787","EFO_1001100","EFO_0005537","HP_0004326","EFO_0002428","EFO_0000233","EFO_0000432","EFO_0006544","EFO_1000613","MONDO_0021355","EFO_1000172","EFO_0002938","MONDO_0004192","EFO_0003866","EFO_0004230","EFO_0000708","MONDO_0021063","MONDO_0002087","MONDO_0024879","EFO_0000305","EFO_1000357","MONDO_0001187","EFO_0007362","EFO_1001480","EFO_1000044","EFO_1000043","MONDO_0001475","EFO_0003860","EFO_0006352","EFO_0000673","EFO_1001963","EFO_0002617","EFO_0002914","MONDO_0001402","EFO_0000503","EFO_0000313","EFO_0003060","EFO_1001214","EFO_0000311","EFO_0003863","EFO_0005570","EFO_0003865","EFO_0010282","EFO_0006861","MONDO_0003219","MONDO_0001325","EFO_0000691","EFO_0000181"],"count":136},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 105 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545303","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(-c3nnn[nH]3)c2)c1O","inchiKey":"IIBBJCNVTRCTDV-QYQHSDTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOTROMBOPAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-2285921","Gsk2285921","LGD-4665","Lgd-4665","SB-559448","Totrombopag"],"childChemblIds":["CHEMBL3545302"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545398","drugType":"Small molecule","blackBoxWarning":false,"name":"PG-760564","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pg-760564"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL363381","canonicalSmiles":"O=C(O)[C@]1(O)C/C(=N\\O)[C@@H](O)[C@H](O)C1","inchiKey":"WASIBXJFRXJWAR-GKQOBJDDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03739"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707357","drugType":"Antibody","blackBoxWarning":false,"name":"BROLUCIZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beovu"],"synonyms":["Brolucizumab","Brolucizumab-dbll","ESBA-1008","ESBA1008","RTH-258","RTH258"],"crossReferences":{"DailyMed":["brolucizumab-dbll"]},"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","EFO_0004683","EFO_0001365","EFO_1001157","EFO_0005753","EFO_0009322","EFO_0009321"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for ocular vascular disease and has 4 investigational indications."}
{"id":"CHEMBL380373","canonicalSmiles":"CC(C)n1c(Nc2ccccc2F)nc2cnc(Oc3c(F)cccc3F)nc21","inchiKey":"OGWSGDLIXOEZJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380373","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08097"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382201","canonicalSmiles":"COc1ccc(-c2ccc(S(=O)(=O)N[C@H](C(C)C)P(=O)(O)O)cc2)cc1","inchiKey":"BZVYQWLRCHLAGK-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL382201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL386115","canonicalSmiles":"CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC)[C@@H](C)CC","inchiKey":"RIWLPSIAFBLILR-WVNGMBSFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ABT-510","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT 510","ABT-526","Abt 510","Abt-510"],"crossReferences":{"drugbank":["DB05434"]},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3989520","canonicalSmiles":"NCCc1c[nH]cn1.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"ZHIBQGJKHVBLJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HISTAMINE PHOSPHATE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL90","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Histamine phosphate"],"synonyms":["Histamine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989525","canonicalSmiles":"[N-]=[N+]=NCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1","inchiKey":"SGRUZFCHLOFYHZ-MWLCHTKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIDAMFENICOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azidamfenicol","Azidoamfenicol","Azidoamphenicol","Posifenicol"],"crossReferences":{"drugbank":["DB13294"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989824","canonicalSmiles":"CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O","inchiKey":"MEUAAEMCZUPORO-LRSHZYOCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIOTHIXENE HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navane","Thiothixene hydrochloride","Thiothixene hydrochloride intensol"],"synonyms":["CP-12,252-1","CP-122521","Thiothixene hcl h20","Thiothixene hydrochloride","Tiotixene hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970. This drug has a black box warning from the FDA."}
{"id":"CHEMBL405130","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC","inchiKey":"HOZUXBLMYUPGPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WHI-P131","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JANEX-1","Janex 1","WHI-P131","Whi-p131"],"childChemblIds":["CHEMBL555201"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4078100","canonicalSmiles":"COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12","inchiKey":"RSMYFSPOTCDHHJ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-5153","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5153","AZD5153","Azd 5153","Azd-5153","Azd5153"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4080062","canonicalSmiles":"O=C(Nc1cccc(C(F)(F)F)c1)c1cccc2cc(Oc3cc(CO)ncn3)ccc12","inchiKey":"JNLSTLQFDDAULK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BFH-772","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BFH-722","BFH-772","BFH722","BFH772","Bfh-772","Bfh772"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL411907","canonicalSmiles":"C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C","inchiKey":"QIUASFSNWYMDFS-NILGECQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SONOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PX-866","Px-866","Sonolisib"],"crossReferences":{"drugbank":["DB12601"],"chEBI":["65345"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008315","EFO_0000519","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL41306","canonicalSmiles":"CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1","inchiKey":"JHVHEDNLONERHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CNS-5161","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cns 5161","Cns-5161"],"crossReferences":{"drugbank":["DB05824"]},"childChemblIds":["CHEMBL1079972"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4173394","canonicalSmiles":"CCOc1ccc(Nc2ccc(/C(=C3/C=C/C(=[N+](/CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3C)c3ccc(N(CC)Cc4cccc(S(=O)(=O)[O-])c4)cc3C)cc2)cc1.[Na+]","inchiKey":"RWVGQQGBQSJDQV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BRILLIANT BLUE G","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4301898","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tissueblue"],"synonyms":["Bbg-250","Brilliant blue g","C.i. acid blue 90","Coomassie blue g 250","Coomassie blue g-250","Coomassie brilliant blue g","NSC-328382"],"crossReferences":{"DailyMed":["brilliant%20blue%20g"],"drugbank":["DB15594"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019."}
{"id":"CHEMBL4297323","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"VZRIKWNVDCTBTF-BKGFHLQYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PZ-128","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Palmitate-kksralf-nh2","Pz-128"],"crossReferences":{"drugbank":["DB11839"]},"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0001645"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297380","canonicalSmiles":"CCCCCc1ccc(-c2cc3cn([C@H]4C[C@H](O)[C@@H](COC(=O)[C@@H](N)C(C)C)O4)c(=O)nc3o2)cc1.Cl","inchiKey":"CAHTYTZOAVUCIU-ZMQZINMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALNIVUDINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300944","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fv-100","Valnivudine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297563","drugType":"Antibody","blackBoxWarning":false,"name":"PACMILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-072","CX-072 PROBODY","CX072","Cx 072","Cx-072","Pacmilimab"],"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0000574","EFO_0002617"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297666","canonicalSmiles":"CC(C)OC(=O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1","inchiKey":"VIQCWEGEHRBLAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIDENEPAG ISOPROPYL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DE-117","De-117","Omidenepag isopropyl"],"crossReferences":{"drugbank":["DB15071"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297731","drugType":"Unknown","blackBoxWarning":false,"name":"COPPER HISTIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bishistidine copper(ii) salt","Copper histidine","Copper, bis(l-histidinato)-","Copper, bis(l-histidinato-n,o)-","J1.412.545K"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298206","drugType":"Gene","blackBoxWarning":false,"name":"TAVOKINOGENE TELSEPLASMID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Immunopulse il-12"],"synonyms":["12-NGVL331","Dna plasmid encoding interleukin-12 ino-9012","PNGVL3-HIL-12","Tavokinogene telseplasmid","pUMVC3-hIL"],"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL434200","canonicalSmiles":"CC(C)(C)NCC(O)COc1cccc2c1SCCC2","inchiKey":"HTWFXPCUFWKXOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERTATOLOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artex"],"synonyms":["Artexal","Prenalex","S-2395","SE-2395","Tertatolol","Tertatolol hydrochloride"],"crossReferences":{"Wikipedia":["Tertatolol"],"drugbank":["DB13775"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL444422","canonicalSmiles":"N=C(N)SCCc1ccc(CCSC(=N)N)cc1","inchiKey":"FZWGDUUJDZCYJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL444422","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111673","50111205","90341115"],"drugbank":["DB02141"]},"childChemblIds":["CHEMBL1451880"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451666","canonicalSmiles":"CCSC(=N)Nc1ccccc1","inchiKey":"LAXNJIWNBHHMDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL451666","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03707"]},"childChemblIds":["CHEMBL545673"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453509","canonicalSmiles":"CCCCCC/C=C\\CCCCCCCC(=O)O","inchiKey":"SECPZKHBENQXJG-FPLPWBNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALMITOLEIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Palmitoleic Acid","Palmitoleicacid"],"crossReferences":{"PubChem":["144211267"],"drugbank":["DB04257"],"chEBI":["28716"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458926","canonicalSmiles":"CC(C)Nc1cc(Cl)nc2c(C#N)cnn12","inchiKey":"HFTLYNKTSANXFA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458926","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08139"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594357","drugType":"Antibody","blackBoxWarning":false,"name":"IANALUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ianalumab","NVP-VAY736","VAY-736","VAY736","Vay736"],"linkedTargets":{"rows":["ENSG00000159958"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761","EFO_0000699"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4594428","canonicalSmiles":"COc1cc(OC)c(F)c(COc2cnc(Nc3cnn(CCO)c3)nc2)c1F","inchiKey":"VDZZYOJYLLNBTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASP-5878","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-5878","ASP5878","Asp 5878","Asp-5878","Asp5878"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594556","drugType":"Unknown","blackBoxWarning":false,"name":"IGN-523","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AML-01","IGN-523","IGN523","Ign-523","Ign523"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4646511","canonicalSmiles":"CO[C@H]1C[C@H](C)CC2=C(NCCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)C(=O)C=C(NC(=O)/C(C)=C/C=C\\[C@H](OC)C[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@H]1O)C2=O","inchiKey":"PMARJMMYAAMURY-FATWHCHZSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMITRINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G-tpp","Gamitrinib","Gamitrinib tpp"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650363","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCCC[C@@H]1CCSS1.[Cl-]","inchiKey":"QMADNKDMPGZUKN-UTONKHPSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":".ALPHA.-R-LIPOIC ACID CHOLINE ESTER CHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4650743","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-r-lipoic acid choline ester chloride","Choline lipoate chloride","EV-06 CHLORIDE","EV06 CHLORIDE","Lace chloride","UMR-844","UMR-844 CHLORIDE","UNR844","UNR844 CHLORIDE","Unr844"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650392","drugType":"Antibody","blackBoxWarning":false,"name":"DOMVANALIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-154","AB154","Ab154","Domvanalimab"],"linkedTargets":{"rows":["ENSG00000181847"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","EFO_0003060","EFO_0000519"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650469","drugType":"Antibody","blackBoxWarning":false,"name":"DEPEMOKIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AQ-82742999","AQ82742999","Depemokimab","GSK-3511294","GSK3511294","Gsk3511294"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL466496","canonicalSmiles":"C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1","inchiKey":"MCBPNFWHHNJTGN-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL466496","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07234"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478120","canonicalSmiles":"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1","inchiKey":"BPFYOAJNDMUVBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARBOFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Marbocyl","Marbofloxacin","RO 09-1168"],"crossReferences":{"PubChem":["144205959","170465732","174006196","26660734","29218068"],"Wikipedia":["Marbofloxacin"],"drugbank":["DB11426"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489586","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1","inchiKey":"KXDIHAQCVNNLIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-4965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-4965"],"crossReferences":{"drugbank":["DB08460"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL498485","canonicalSmiles":"COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O)cc1","inchiKey":"TUUXBSASAQJECY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICARITIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Icaritin","SGN-162","SGN162"],"crossReferences":{"drugbank":["DB12672"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL61780","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO","inchiKey":"TUYWTLTWNJOZNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZOSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Veletri"],"synonyms":["ACT-050089","Ro 61-0612","Ro-610612","Tezosentan"],"crossReferences":{"Wikipedia":["Tezosentan"],"drugbank":["DB06558"]},"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["EFO_0001361","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL6246","canonicalSmiles":"O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23","inchiKey":"AFSDNFLWKVMVRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELLAGIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoaric acid","Ellagic acid","NSC-407286","NSC-656272"],"crossReferences":{"PubChem":["104171339","11113162","124882875","124882878","144204356","170466649","26514067","26748644","26748645","26753737","477072","50123014","8139882"],"Wikipedia":["Ellagic_acid"],"drugbank":["DB08846"],"chEBI":["4775"]},"childChemblIds":["CHEMBL4591559"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL655","canonicalSmiles":"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2","inchiKey":"DDLIGBOFAVUZHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDAZOLAM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"crossReferences":{"DailyMed":["midazolam","midazolam%20hydrochloride"],"PubChem":["50113067"],"Wikipedia":["Midazolam"],"drugbank":["DB00683"],"chEBI":["6931"]},"childChemblIds":["CHEMBL2106922","CHEMBL1200420"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0002610","EFO_0003768","EFO_0005952","EFO_0003914","HP_0100543","EFO_0003931","EFO_0000588","EFO_0003819","EFO_0009513","MONDO_0008903","EFO_0007157","EFO_0000676","MONDO_0004976","EFO_0008526","EFO_0009686","HP_0001623","HP_0012532","HP_0012076","EFO_0006911","EFO_0005323","EFO_0000662","EFO_0000384","MONDO_0008315","EFO_0000546","EFO_0001422","MP_0001914","EFO_0005741","EFO_1000049","HP_0001336","EFO_0007328","EFO_0007634","EFO_0001378","EFO_0003767","EFO_0004320","HP_0000726","MONDO_0007254","EFO_1001413","EFO_1000637","EFO_0000289","MONDO_0002050","MONDO_0005180","EFO_0009854","EFO_0000616","EFO_0005774","MONDO_0021204","EFO_0003832","EFO_0001645","EFO_0002623","Orphanet_44890","HP_0011110","EFO_0003929","EFO_0000222","EFO_0001358","EFO_0000319","EFO_0000618","HP_0001250","EFO_0001073","EFO_0003843","EFO_0000537","HP_0000713","EFO_0004220","EFO_0000764","MONDO_0043510","Orphanet_337","MONDO_0005148","MONDO_0024880","EFO_0005411","MONDO_0005178","EFO_0008525","EFO_0000729","EFO_0003869","HP_0000989","MONDO_0002009","HP_0012735","EFO_1001328","EFO_0003015","HP_0001298","EFO_0000540","HP_0100790","EFO_0000544","EFO_1001134","HP_0003419","HP_0012378","EFO_0007623","EFO_0001074","EFO_0000701","Orphanet_3389","EFO_0004239","HP_0100806","MONDO_0100096","HP_0002045","HP_0030833","EFO_0004888","EFO_0005251","EFO_0009878","MONDO_0005090","EFO_0006834","EFO_1001494","Orphanet_232","EFO_0001065","EFO_1001905","EFO_1001454","EFO_1001249","EFO_0009267","EFO_0000274","Orphanet_68380","HP_0000083","EFO_0000474","EFO_0003144","MONDO_0005129","EFO_0000673","EFO_0004272","EFO_0003047","EFO_0004242","MONDO_0007079","EFO_0005230","EFO_0003030","EFO_0002617","EFO_0000685","HP_0002140","EFO_0000545","EFO_1001884","EFO_0003060","EFO_0000311","EFO_0003863","EFO_0003890","EFO_0000713","EFO_0001068","EFO_0000095","EFO_0003854","MONDO_0004975","EFO_0005611"],"count":132},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 98 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL787","canonicalSmiles":"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1","inchiKey":"UCHDWCPVSPXUMX-TZIWLTJVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MONTELUKAST","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Singulair"],"synonyms":["Brondilat","MK-476","Montelukast"],"crossReferences":{"DailyMed":["montelukast%20sodium"],"Wikipedia":["Montelukast"],"drugbank":["DB00471"],"chEBI":["50730"]},"childChemblIds":["CHEMBL1200681"],"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["Orphanet_64739","Orphanet_232","HP_0012735","EFO_0007183","EFO_0003095","EFO_0010638","EFO_1001249","EFO_0000274","EFO_0000540","EFO_0009715","HP_0011950","EFO_0009836","Orphanet_70589","HP_0040187","EFO_0000544","EFO_0003917","EFO_1001417","EFO_0003877","EFO_0005854","EFO_0000694","EFO_0008521","EFO_0000685","EFO_0000220","EFO_0008590","EFO_0001645","EFO_0009661","EFO_0000222","MONDO_0002465","EFO_1002029","EFO_0003843","EFO_0004232","HP_0100806","HP_0006536","MONDO_0100096","EFO_0000684","MONDO_0005301","EFO_0000649","EFO_0000764","MONDO_0004975","MONDO_0004979","EFO_0001378","HP_0025428","EFO_0000341","EFO_0004227","EFO_0003918","EFO_0005672","EFO_0003956"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 31 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL821","canonicalSmiles":"N=C(N)N","inchiKey":"ZRALSGWEFCBTJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANIDINE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Guanidine"],"crossReferences":{"Wikipedia":["Guanidine"],"drugbank":["DB00536"],"chEBI":["42820"]},"childChemblIds":["CHEMBL1200728","CHEMBL3187576"],"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000053918","ENSG00000168263","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000135519","ENSG00000177301","ENSG00000168418","ENSG00000089558","ENSG00000158445","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["HP_0001324","EFO_1001901","EFO_0008524","EFO_0004991","EFO_0009708"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1939 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL889","canonicalSmiles":"O=P(O)(NCCCl)NCCCl","inchiKey":"BKCJZNIZRWYHBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALIFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPM","Ifosfamide mustard","Isophosphamide mustard","N,N'-Bis-(2-Chloroethyl)Phosphoric Acid","NSC-297900","Palifosfamide","ZIO-201"],"crossReferences":{"PubChem":["147379"],"drugbank":["DB05668"],"chEBI":["80566"]},"childChemblIds":["CHEMBL2219419"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL91397","canonicalSmiles":"Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1","inchiKey":"WUZYKBABMWJHDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUPATADINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rupatadine","UR-12592"],"crossReferences":{"Wikipedia":["Rupatadine"],"drugbank":["DB11614"]},"linkedTargets":{"rows":["ENSG00000169403","ENSG00000196639"],"count":2},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000685","EFO_0005531","MONDO_0005271","EFO_0009001","EFO_1001881"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL942","canonicalSmiles":"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1","inchiKey":"KHOITXIGCFIULA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISACODYL","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biolax","Correctol tablets, caplets","Dulcodos","Dulcolax","Entrolax","Feen-a-mint tablets","Sk-bisacodyl","Theralax"],"synonyms":["Bisacodyl","Evac-q-tabs","Modane","NSC-755914"],"crossReferences":{"PubChem":["104171309","11112427","124882357","144204023","144207536","170464843","17389548","26747020","26747021","487150","50100436","855868"],"Wikipedia":["Bisacodyl"],"drugbank":["DB09020"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for constipation and constipation disorder."}
{"id":"CHEMBL944","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1Cl.Cl","inchiKey":"SZKQYDBPUCZLRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPROCAINE HYDROCHLORIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1179047","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ampres","Chloroprocaine hydrochloride","Clorotekal","Nesacaine","Nesacaine-mpf"],"synonyms":["Chloroprocaine HCl","Chloroprocaine hcl","Chloroprocaine hydrochloride","Chlorprocaine chloride"],"crossReferences":{"DailyMed":["chloroprocaine%20hydrochloride"],"PubChem":["144206478"],"chEBI":["3637"]},"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955 and has 1 investigational indication."}
{"id":"CHEMBL95700","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(C(=O)/C=C/c3ccc(C(=O)O)cc3)ccc21","inchiKey":"ZXQHMEUGMCXKLO-KPKJPENVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL95700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02466"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
